Impact of the Hemostasis and Thrombosis Research Society trainee workshop in recruiting the next generation of nonmalignant hematologists.


Journal

Journal of thrombosis and thrombolysis
ISSN: 1573-742X
Titre abrégé: J Thromb Thrombolysis
Pays: Netherlands
ID NLM: 9502018

Informations de publication

Date de publication:
Apr 2020
Historique:
pubmed: 13 11 2019
medline: 21 1 2021
entrez: 13 11 2019
Statut: ppublish

Résumé

The United States is facing a shortage of physicians dedicated to nonmalignant hematology to meet future needs. The Hemostasis and Thrombosis Research Society (HTRS) developed a medical education program for trainees, "HTRS Trainee Workshops: Building a Career in Hemostasis and Thrombosis" in 2016. The aim of this study is to evaluate the impact of the workshop in recruiting the next generation of nonmalignant hematologists. Two surveys (post-workshop survey and alumni survey) were conducted. The post-workshop survey occurred within 30 days of each workshop and was completed by 81.9% (n = 185) of participants. Majority of respondents reported that the workshop had a positive impact to their practice and/or research (93.0%, n = 174) and career development (87.7%, n = 164). For the alumni survey which was conducted in 2018, 73 participants responded to the survey (38.2% response rate). Of the 38 respondents who had graduated from fellowship at the time of the survey, almost all chose a career in academic medicine. 41.7% (n = 15) reported their specialty as adult nonmalignant hematology and 25.0% (n = 9) as pediatric hematology/oncology with a nonmalignant hematology focus. 41.1% (n = 30) developed collaborative professional relationships, and 78.1% (n = 57) reported that the workshop had a positive influence in their choice to pursue nonmalignant hematology as a career. 67.1% (n = 49) were actively involved in research in nonmalignant hematology, with the most common being clinical research. This survey suggests that the HTRS Trainee Workshop is meeting its goals to recruit, train, and mentor the next generation of nonmalignant hematologists.

Identifiants

pubmed: 31712946
doi: 10.1007/s11239-019-01990-y
pii: 10.1007/s11239-019-01990-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-456

Références

J Gen Intern Med. 2006 Dec;21(12):1222-9
pubmed: 17105520
Blood. 2015 Apr 16;125(16):2467-70
pubmed: 25746327
Blood. 2015 Apr 30;125(18):2745-52
pubmed: 25758827
Blood Adv. 2018 Feb 27;2(4):361-369
pubmed: 29463548

Auteurs

Ming Y Lim (MY)

Division of Hematology and Hematological Malignancies, Department of Medicine, University of Utah, 2000 Circle of Hope Rm 4126, Salt Lake City, UT, 84112, USA. mylim@cantab.net.

Kathy Blaszczyk (K)

Hemostasis and Thrombosis Research Society, Milwaukee, WI, USA.

Lorilyn Jacobsen-Tews (L)

Hemostasis and Thrombosis Research Society, Milwaukee, WI, USA.

Laura Mott (L)

Hemostasis and Thrombosis Research Society, Milwaukee, WI, USA.

Ravindra Sarode (R)

Division of Transfusion Medicine and Hemostasis, Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.

Jennifer Ziegler (J)

Hemostasis and Thrombosis Research Society, Milwaukee, WI, USA.

Arash Mahajerin (A)

Division of Hematology, CHOC Children's Specialists, Orange, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH